Post-Authorization Safety Studies of Medicinal Products

The PASS Book

Nonfiction, Health & Well Being, Medical, Specialties, Pharmacy, Medical Science, Pharmacology
Cover of the book Post-Authorization Safety Studies of Medicinal Products by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128092088
Publisher: Elsevier Science Publication: June 27, 2018
Imprint: Academic Press Language: English
Author:
ISBN: 9780128092088
Publisher: Elsevier Science
Publication: June 27, 2018
Imprint: Academic Press
Language: English

Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in the literature by providing a complete look at post-authorization safety studies and important pharmacoepidemiology and pharmacovigilance aspects. It covers various types and limitations of active surveillance programs, including the use of large databases and disparate data sources for rapid signal detection, as well as novel and advanced design and analysis approaches for causal interference from observational data. This book serves as an important reference for pharmacovigilance scientists and pharmacoepidemiologists who are searching for the appropriate study design to answer safety research questions.

Readers will be able to effectively and efficiently design and interpret findings from post-authorization safety studies with the goal of improving the benefit-risk balance of a drug in order to optimize patient safety.

  • Discusses all types of observational studies in post-marketing drug safety assessment, from spontaneous reporting systems, to pragmatic trials, with examples from real-world settings
  • Presents various types of post-authorization safety studies
  • Offers solutions to the common challenges in the design and conduct of these studies
  • Highlights active surveillance programs, including common data models for rapid signal detection of drug safety issues
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in the literature by providing a complete look at post-authorization safety studies and important pharmacoepidemiology and pharmacovigilance aspects. It covers various types and limitations of active surveillance programs, including the use of large databases and disparate data sources for rapid signal detection, as well as novel and advanced design and analysis approaches for causal interference from observational data. This book serves as an important reference for pharmacovigilance scientists and pharmacoepidemiologists who are searching for the appropriate study design to answer safety research questions.

Readers will be able to effectively and efficiently design and interpret findings from post-authorization safety studies with the goal of improving the benefit-risk balance of a drug in order to optimize patient safety.

More books from Elsevier Science

Cover of the book The Mendip Caves by
Cover of the book Paleoclimatology by
Cover of the book Bone Response to Dental Implant Materials by
Cover of the book Recombinant DNA Methodology II by
Cover of the book Glucosinolates by
Cover of the book Advances in Agronomy by
Cover of the book Rehabilitation of Pipelines Using Fiber-reinforced Polymer (FRP) Composites by
Cover of the book Oxidative Stability and Shelf Life of Foods Containing Oils and Fats by
Cover of the book Quantitative Functional Brain Imaging with Positron Emission Tomography by
Cover of the book The Biogas Handbook by
Cover of the book Oral Physiology by
Cover of the book Advances in Immunology by
Cover of the book The Circuit Designer's Companion by
Cover of the book Chemical and Biochemical Approaches for the Study of Anesthetic Function Part B by
Cover of the book Mid-Career Library and Information Professionals by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy